Adventitial endothelial implants reduce matrix metalloproteinase-2 expression and increase luminal diameter in porcine arteriovenous grafts

Journal of Vascular Surgery

Volumn 46, Issue 3, 2007, Pages

  Nugent, Helen M ^a,b   Tjin Tham Sjin, Robert ^b   White, Desmond ^b   Milton, Luther G ^c   Manson, Roberto J ^c   Lawson, Jeffrey H ^c   Edelman, Elazer R ^a,d  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b Pervasis Therapeutics Inc   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELFOAM; POLITEF;

ADVENTITIA; ANASTOMOSIS; ANGIOGRAPHY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL DIAMETER; BLOOD VESSEL GRAFT; BLOOD VESSEL INJURY; CAROTID ARTERY; CONTROLLED STUDY; ENDOPROSTHESIS; ENDOTHELIUM CELL; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; JUGULAR VEIN; MALE; MOLECULAR MECHANICS; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWINE; VASCULAR FIBROSIS; VEIN DIAMETER;

EID: 34548445824     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2007.04.074     Document Type: Article

References (39)

1. Woods J.D., Turenne M.N., Strawderman R.L., Young E.W., Hirth R.A., Port F.K., et al. Vascular access survival among incident hemodialysis patients in the United States. Am J Kidney Dis 30 (1997) 50-57
2. Dixon B.S., Novak L., and Fangman J. Hemodialysis vascular access survival: upper-arm native arteriovenous fistula. Am J Kidney Dis 39 (2002) 92-101
3. Beathard G.A. The treatment of vascular access graft dysfunction: a nephrologist's view and experience. Advances in renal replacement therapy 1 (1994) 131-147
4. Roy-Chaudhury P., Kelly B.S., Narayana A., Desai P., Melhem M., Munda R., et al. Hemodialysis vascular access dysfunction from basic biology to clinical intervention. Advances in renal replacement therapy 9 (2002) 74-84
5. Quinn S.F., Schuman E.S., Demlow T.A., Standage B.A., Ragsdale J.W., Green G.S., et al. Percutaneous transluminal angioplasty versus endovascular stent placement in the treatment of venous stenoses in patients undergoing hemodialysis: intermediate results. J Vasc Interv Radiol 6 (1995) 851-855
6. Mickley V., Gorich J., Rilinger N., Storck M., and Abendroth D. Stenting of central venous stenoses in hemodialysis patients: long-term results. Kidney Int 51 (1997) 277-280
7. Gotoh R., Suzuki J., Kosuge H., Kakuta T., Sakamoto S., Yoshida M., et al. E-selectin blockade decreases adventitial inflammation and attenuates intimal hyperplasia in rat carotid arteries after balloon injury. Arterioscler Thromb Vasc Biol 24 (2004) 2063-2068
8. Scott N.A., Cipolla G.D., Ross C.E., Dunn B., Martin F.H., Simonet L., et al. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation 93 (1996) 2178-2187
9. Khurana R., Zhuang Z., Bhardwaj S., Murakami M., De Muinck E., Yla-Herttuala S., et al. Angiogenesis-dependent and independent phases of intimal hyperplasia. Circulation 110 (2004) 2436-2443 19
10. Fleiner M., Kummer M., Mirlacher M., Sauter G., Cathomas G., Krapf R., et al. Arterial neovascularization and inflammation in vulnerable patients: early and late signs of symptomatic atherosclerosis. Circulation 110 (2004) 2843-2850
11. Nugent H.M., Rogers C., and Edelman E.R. Endothelial implants inhibit intimal hyperplasia after porcine angioplasty. Circ Res 84 (1999) 384-391
12. Nugent H.M., and Edelman E.R. Endothelial implants provide long-term control of vascular repair in a porcine model of arterial injury. J Surg Res 99 (2001) 228-234
13. Nugent H.M., Groothuis A., Seifert P., Guerraro J.L., Nedelman M., Mohanakumar T., et al. Perivascular endothelial implants inhibit intimal hyperplasia in a model of arteriovenous fistulae: a safety and efficacy study in the pig. J Vasc Res 39 (2002) 524-533
14. Baig K., Fields R.C., Gaca J., Hanish S., Milton L.G., Koch W.J., et al. A porcine model of intimal-medial hyperplasia in polytetrafluoroethylene arteriovenous grafts. J Vasc Access 4 (2003) 111-117
15. Kelly B.S., Narayana A., Heffelfinger S.C., Denman D., Miller M.A., Elson H., et al. External beam radiation attenuates venous neointimal hyperplasia in a pig model of arteriovenous polytetrafluoroethylene (PTFE) graft stenosis. Int J Radiat Oncol Biol Phys 54 (2002) 263-269
16. Fields R.C., Baig K., Gaca J., Milton L.G., Koch W.J., and Lawson J.H. Reduction of vascular intimal-medial hyperplasia in polytetrafluoroethylene arteriovenous grafts via expression of an inhibitor of G protein signaling. Ann Vasc Surg 19 (2005) 712-718
17. Rotmans J.I., Pattynama P.M., Verhagen H.J., Hino I., Velema E., Pasterkamp G., et al. Sirolimus-eluting stents to abolish intimal hyperplasia and improve flow in porcine arteriovenous grafts: a 4-week follow-up study. Circulation 111 (2005) 1537-1542
18. Rotmans J.I., Velema E., Verhagen H.J.M., Blankensteijn J.D., de Kleijn D.P.V., Stroes E.S.G., et al. Matrix metalloproteinases inhibition reduces intimal hyperplasia in a porcine arteriovenous-graft model. J Vasc Surg 39 (2004) 432-439
19. Rey F.E., and Pagano P.J. The reactive adventitia: fibroblast oxidase in vascular function. Arterioscler Thromb Vasc Biol 22 (2002) 1962-1971
20. Li G., Chen S.J., Oparil S., Chen Y.F., and Thompson J.A. Direct in vivo evidence demonstrating neointimal migration of adventitial fibroblasts after balloon injury of rat carotid arteries. Circulation 101 (2000) 1362-1365
21. Zalewski A., and Shi Y. Vascular myofibroblasts. Lessons from coronary repair and remodeling. Arterioscler Thromb Vasc Biol 17 (1997) 417-422
22. Nagase H., and Woessner Jr. J.F. Matrix metalloproteinases. J Biol Chem 274 (1999) 21491-21494
23. Bode W., Fernandez-Catalan C., Grams F., Gomis-Ruth F.X., Nagase H., Tschesche H., et al. Insights into MMP-TIMP interactions. Ann NY Acad Sci 878 (1999) 73-91
24. Galis Z.S., and Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 90 (2002) 251-262
25. Southgate K.M., Mehta D., Izzat M.B., Newby A.C., and Angelini G.D. Increased secretion of basement membrane-degrading metalloproteinases in pig saphenous vein into carotid artery interposition grafts. Arterioscler Thromb Vasc Biol 19 (1999) 1640-1649
26. Misra S., Doherty M.G., Woodrum D., Homburger J., Mandrekar J.N., Elkouri S., et al. Adventitial remodeling with increased matrix metalloproteinase-2 activity in a porcine arteriovenous polytetrafluoroethylene grafts. Kidney Int 68 (2005) 2890-2900
27. Haas T.L., Milkiewicz M., Davis S.J., Zhou A.L., Egginton S., Brown M.D., et al. Matrix metalloproteinase activity is required for activity-induced angiogenesis in rat skeletal muscle. Am J Physiol 279 (2000) H1540-H1547
28. Shigematsu K., Yasuhara H., and Shigematsu H. Topical application of antiangiogenic agent AGM-1470 suppresses anastomotic intimal hyperplasia after ePTFE grafting in a rabbit model. Surgery 129 (2001) 220-230
29. Haas T.L., Davis S.J., and Madri J.A. Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells. J Biol Chem 273 (1998) 3604-3610
30. Castellot Jr. J.J., Addonizio M.L., Rosenberg R., and Karnovsky M.J. Cultured endothelial cells produce a heparinlike inhibitor of smooth muscle cell growth. J Cell Biol 90 (1981) 372-379
31. Furchgott R.F., and Vanhoutte P.M. Endothelium-derived relaxing and contracting factors. FASEB J 3 (1989) 2007-2018
32. Rubanyi G.M. The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol 22 suppl 4 (1993) S1-S14
33. Kojima T., Leone C.W., Marchildon G.A., Marcum J.A., and Rosenberg R.D. Isolation and characterization of heparan sulfate proteoglycans produced by cloned rat microvascular endothelial cells. J Biol Chem 267 (1992) 4859-4869
34. Forsten K.E., Courant N.A., and Nugent M.A. Endothelial proteoglycans inhibit bFGF binding and mitogenesis. J Cell Physiol 172 (1997) 209-220
35. Dinbergs I.D., Brown L., and Edelman E.R. Cellular response to transforming growth factor-beta1 and basic fibroblast growth factor depends on release kinetics and extracellular matrix interactions. J Biol Chem 271 (1996) 29822-29829
36. Borrelli V., di Marzo L., Sapienza P., Colasanti M., Moroni E., and Cavallaro A. Role of platelet-derived growth factor and transforming growth factor beta1 the in the regulation of metalloproteinase expressions. Surgery 140 (2006) 454-463
37. Hoegy S.E., Oh H.R., Corcoran M.L., and Stetler-Stevenson W.G. Tissue inhibitor of metalloproteinases-2 (TIMP-2) suppresses TKR-growth factor signaling independent of metalloproteinase inhibition. J Biol Chem 276 (2001) 3203-3214
38. Scott-Burden T., and Vanhoutte P.M. Regulation of smooth muscle cell growth by endothelium-derived factors. Tex Heart Inst J 21 (1994) 91-97
39. Gurjar M.V., Sharma R.V., and Bhalla R.C. eNOS gene transfer inhibits smooth muscle cell migration and MMP-2 and MMP-9 activity. Arterioscler Thromb Vasc Biol 19 (1999) 2871-2877